Toronto-Dominion Bank »

Royalty Pharma shares owned by Toronto-Dominion Bank

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Toronto-Dominion Bank from 13F filings

Historical chart of Toronto-Dominion Bank investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Toronto-Dominion Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Toronto-Dominion Bank

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.8M 103k 27.14

More positions owned by Toronto-Dominion Bank

Charles Schwab Corporation (SCHW)
Invesco QQQ Trust Series 1 Etf (QQQ)
Rbc Cad (RY)
Apple (AAPL)
Microsoft Corporation (MSFT)
SPDR S&P 500 ETF Trust Etf (SPY)
iShares Russell 2000 ETF Etf (IWM)
Bank Of Montreal Cadcom (BMO)
Cibc Cad (CM)
Bk Nova Cad (BNS)
Tc Energy Corp (TRP)
Tor Dom Bk Cad (TD)
SPDR Gold Shares Etf (GLD)
NVIDIA Corporation (NVDA)
Canadian Natural Resources (CNQ)

View all positions for Toronto-Dominion Bank

Top funds holding Royalty Pharma

Vanguard Group
Baillie Gifford & Co
Viking Global Investors
Jpmorgan Chase & Co
Unisphere Establishment
Norges Bank Investment Management
Amundi
Siguler Guff Advisers
Legal & General Group
Goldman Sachs Group
Man Group
CalPERS
Two Sigma Investments
Two Sigma Advisers
Henderson Group

View all funds holding Royalty Pharma